Nanjing Vishee Medical Technology Co., Ltd
Simbol: 688580.SS
SHH
47.44
CNYPrețul de piață astăzi
25.8198
Raportul P/E
0.0000
Raportul PEG
3.23B
MRK Cap
- 0.01%
Randament DIV
Nanjing Vishee Medical Technology Co., Ltd (688580-SS) Situații financiare
Bilanț
common:word.in-mln USD Growth | TTM | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2014 | 2013 | |||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
balance-sheet.row.cash-and-short-term-investments | 0 | 1155 | 1248.1 | 1366 | ||||||||||
balance-sheet.row.short-term-investments | 0 | 2266.4 | 0 | 0 | ||||||||||
balance-sheet.row.net-receivables | 0 | 47.3 | 31.9 | 36.7 | ||||||||||
balance-sheet.row.inventory | 0 | 39.9 | 34.8 | 30.4 | ||||||||||
balance-sheet.row.other-current-assets | 0 | 12.6 | 4.3 | 1.2 | ||||||||||
balance-sheet.row.total-current-assets | 0 | 1254.8 | 1319.2 | 1434.3 | ||||||||||
balance-sheet.row.property-plant-equipment-net | 0 | 321.5 | 172.5 | 100.3 | ||||||||||
balance-sheet.row.goodwill | 0 | 69.3 | 69.3 | 0 | ||||||||||
balance-sheet.row.intangible-assets | 0 | 120.6 | 106.5 | 18.8 | ||||||||||
balance-sheet.row.goodwill-and-intangible-assets | 0 | 189.9 | 175.8 | 18.8 | ||||||||||
balance-sheet.row.long-term-investments | 0 | -2244.3 | 0 | 0.8 | ||||||||||
balance-sheet.row.tax-assets | 0 | 15.1 | 7.9 | 12.7 | ||||||||||
balance-sheet.row.other-non-current-assets | 0 | 2269 | 8.8 | 71.9 | ||||||||||
balance-sheet.row.total-non-current-assets | 0 | 551.2 | 365 | 204.4 | ||||||||||
balance-sheet.row.other-assets | 0 | 0 | 0 | 0 | ||||||||||
balance-sheet.row.total-assets | 0 | 1806 | 1684.2 | 1638.7 | ||||||||||
balance-sheet.row.account-payables | 0 | 18 | 19.7 | 9.3 | ||||||||||
balance-sheet.row.short-term-debt | 0 | 0 | 1.2 | 1.2 | ||||||||||
balance-sheet.row.tax-payables | 0 | 19.6 | 21.1 | 29.3 | ||||||||||
balance-sheet.row.long-term-debt-total | 0 | 0 | 0 | 1.8 | ||||||||||
Deferred Revenue Non Current | 0 | 0 | 0 | 0 | ||||||||||
balance-sheet.row.deferred-tax-liabilities-non-current | 0 | - | - | - | ||||||||||
balance-sheet.row.other-current-liab | 0 | 133.7 | 94.8 | 1.6 | ||||||||||
balance-sheet.row.total-non-current-liabilities | 0 | 27.6 | 26.4 | 1.8 | ||||||||||
balance-sheet.row.other-liabilities | 0 | 0 | 0 | 0 | ||||||||||
balance-sheet.row.capital-lease-obligations | 0 | 0 | 1.2 | 1.8 | ||||||||||
balance-sheet.row.total-liab | 0 | 179.3 | 155.7 | 105.7 | ||||||||||
balance-sheet.row.preferred-stock | 0 | 0 | 0 | 0 | ||||||||||
balance-sheet.row.common-stock | 0 | 68.6 | 68.6 | 68.3 | ||||||||||
balance-sheet.row.retained-earnings | 0 | 438.4 | 349.1 | 344.3 | ||||||||||
balance-sheet.row.accumulated-other-comprehensive-income-loss | 0 | 1588.9 | 34.8 | 58.1 | ||||||||||
balance-sheet.row.other-total-stockholders-equity | 0 | -469.2 | 1076 | 1062.3 | ||||||||||
balance-sheet.row.total-stockholders-equity | 0 | 1626.8 | 1528.5 | 1533.1 | ||||||||||
balance-sheet.row.total-liabilities-and-stockholders-equity | 0 | 1806 | 1684.2 | 1638.7 | ||||||||||
balance-sheet.row.minority-interest | 0 | 0 | 0 | 0 | ||||||||||
balance-sheet.row.total-equity | 0 | 1626.8 | 1528.5 | 1533.1 | ||||||||||
balance-sheet.row.total-liabilities-and-total-equity | 0 | - | - | - | ||||||||||
Total Investments | 0 | 22 | 0 | 0.8 | ||||||||||
balance-sheet.row.total-debt | 0 | 0 | 1.2 | 3 | ||||||||||
balance-sheet.row.net-debt | 0 | -1155 | -1246.9 | -1363 |
Situația fluxurilor de numerar
common:word.in-mln USD Growth | TTM | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2014 | 2013 | |||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|
cash-flows.row.net-income | 0 | 93.8 | 177.5 | 143.1 | |||||||||
cash-flows.row.depreciation-and-amortization | 0 | 17.1 | 11.1 | 8.8 | |||||||||
cash-flows.row.deferred-income-tax | 0 | 2.3 | -8.1 | -1.1 | |||||||||
cash-flows.row.stock-based-compensation | 0 | -2.8 | 21.4 | 1.1 | |||||||||
cash-flows.row.change-in-working-capital | 0 | -8.7 | -33.5 | -19.1 | |||||||||
cash-flows.row.account-receivables | 0 | 7.3 | -13.1 | -15.9 | |||||||||
cash-flows.row.inventory | 0 | 1.8 | 6.7 | -5.6 | |||||||||
cash-flows.row.account-payables | 0 | -20.1 | -19 | 3.4 | |||||||||
cash-flows.row.other-working-capital | 0 | 2.3 | -8.1 | -1.1 | |||||||||
cash-flows.row.other-non-cash-items | 0 | -15.6 | -11 | -12.1 | |||||||||
cash-flows.row.net-cash-provided-by-operating-activities | 0 | 0 | 0 | 0 | |||||||||
cash-flows.row.investments-in-property-plant-an-equipment | 0 | -95.6 | -87.3 | -11.7 | |||||||||
cash-flows.row.acquisitions-net | 0 | -34.2 | 0 | 11.7 | |||||||||
cash-flows.row.purchases-of-investments | 0 | -3648 | -4264 | -2102.4 | |||||||||
cash-flows.row.sales-maturities-of-investments | 0 | 3664 | 4284.6 | 2115.8 | |||||||||
cash-flows.row.other-investing-activites | 0 | 9 | -10 | -11.7 | |||||||||
cash-flows.row.net-cash-used-for-investing-activites | 0 | -104.8 | -76.8 | 1.9 | |||||||||
cash-flows.row.debt-repayment | 0 | -2 | -1.3 | -14 | |||||||||
cash-flows.row.common-stock-issued | 0 | 16.9 | -0.3 | -18 | |||||||||
cash-flows.row.common-stock-repurchased | 0 | -14.9 | 1.6 | 18 | |||||||||
cash-flows.row.dividends-paid | 0 | -88.9 | -71.8 | -50.3 | |||||||||
cash-flows.row.other-financing-activites | 0 | -6.1 | -9.2 | 1059.1 | |||||||||
cash-flows.row.net-cash-used-provided-by-financing-activities | 0 | -95 | -81 | 994.8 | |||||||||
cash-flows.row.effect-of-forex-changes-on-cash | 0 | 0 | 0 | 0 | |||||||||
cash-flows.row.net-change-in-cash | 0 | -113.6 | -0.4 | 1117.4 | |||||||||
cash-flows.row.cash-at-end-of-period | 0 | 1247.7 | 1361.3 | 1361.7 | |||||||||
cash-flows.row.cash-at-beginning-of-period | 0 | 1361.3 | 1361.7 | 244.4 | |||||||||
cash-flows.row.operating-cash-flow | 0 | 86.2 | 157.4 | 120.8 | |||||||||
cash-flows.row.capital-expenditure | 0 | -95.6 | -87.3 | -11.7 | |||||||||
cash-flows.row.free-cash-flow | 0 | -9.4 | 70 | 109.1 |
Rândul din contul de profit și pierdere
common:word.in-mln USD Growth | TTM | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2014 | 2013 | |||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
income-statement-row.row.total-revenue | 0 | 462.2 | 321.6 | 430 | ||||||||||
income-statement-row.row.cost-of-revenue | 0 | 130.5 | 88.5 | 108.5 | ||||||||||
income-statement-row.row.gross-profit | 0 | 331.7 | 233.1 | 321.6 | ||||||||||
income-statement-row.row.gross-profit-ratio | 0 | 0 | 0 | 0 | ||||||||||
income-statement-row.row.research-development | 0 | - | - | - | ||||||||||
income-statement-row.row.selling-general-administrative | 0 | - | - | - | ||||||||||
income-statement-row.row.selling-and-marketing-expenses | 0 | - | - | - | ||||||||||
income-statement-row.row.other-expenses | 0 | 1.6 | 18 | 7.4 | ||||||||||
income-statement-row.row.operating-expenses | 0 | 208.7 | 162.9 | 163.1 | ||||||||||
income-statement-row.row.cost-and-expenses | 0 | 339.2 | 251.4 | 271.6 | ||||||||||
income-statement-row.row.interest-income | 0 | 19.3 | 19.3 | 16.8 | ||||||||||
income-statement-row.row.interest-expense | 0 | 1.3 | 0.3 | 0.2 | ||||||||||
income-statement-row.row.selling-and-marketing-expenses | 0 | - | - | - | ||||||||||
income-statement-row.row.total-other-income-expensenet | 0 | 1.6 | 1.4 | 2.7 | ||||||||||
income-statement-row.row.ebitda-ratio-caps | 0 | - | - | - | ||||||||||
income-statement-row.row.other-operating-expenses | 0 | 1.6 | 18 | 7.4 | ||||||||||
income-statement-row.row.total-operating-expenses | 0 | 1.6 | 1.4 | 2.7 | ||||||||||
income-statement-row.row.interest-expense | 0 | 1.3 | 0.3 | 0.2 | ||||||||||
income-statement-row.row.depreciation-and-amortization | 0 | 20.1 | 19.5 | 14.9 | ||||||||||
income-statement-row.row.ebitda-caps | 0 | - | - | - | ||||||||||
income-statement-row.row.operating-income | 0 | 148.4 | 104.5 | 194.7 | ||||||||||
income-statement-row.row.income-before-tax | 0 | 150 | 105.8 | 197.4 | ||||||||||
income-statement-row.row.income-tax-expense | 0 | 13.8 | 12 | 19.8 | ||||||||||
income-statement-row.row.net-income | 0 | 136.3 | 93.8 | 177.8 |
Întrebări frecvente
Ce este Nanjing Vishee Medical Technology Co., Ltd (688580.SS) totalul activelor?
Nanjing Vishee Medical Technology Co., Ltd (688580.SS) activele totale sunt 1806024041.000.
Care este venitul anual al întreprinderii?
Venitul anual este N/A.
Care este marja de profit a întreprinderii?
Marja de profit a firmei este 0.715.
Care este fluxul de numerar liber al întreprinderii?
Fluxul de numerar liber este -0.334.
Care este marja de profit net a întreprinderii?
Marja profitului net este 0.282.
Care este venitul total al întreprinderii?
Venitul total este 0.306.
Care este Nanjing Vishee Medical Technology Co., Ltd (688580.SS) profitul net (venitul net)?
Profitul net (venitul net) este 136258629.000.
Care este datoria totală a firmei?
Datoria totală este 0.000.
Care este numărul cheltuielilor de exploatare?
Cheltuielile de exploatare sunt 208672734.000.
Care este cifra de numerar a firmei?
Numerarul întreprinderii este 0.000.